Cargando…

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma

PURPOSE: Aristolochic acid (AA) is a carcinogen in upper urinary tract urothelial carcinoma (UTUC). This study investigated the latency period between AA exposure and UTUC development. MATERIALS AND METHODS: This population-based cohort study was designed using record linkage of the National Health...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jhuang, Jing-Rong, Chiu, Po-Chun, Hsieh, Tung-Che, Chen, Chung-Hsin, Pu, Yeong-Shiau, Lee, Wen-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034135/ https://www.ncbi.nlm.nih.gov/pubmed/36969664 http://dx.doi.org/10.3389/fpubh.2023.1072864

Ejemplares similares

Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
por: Chen, Chung-Hsin, et al.
Publicado: (2016)

Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
por: Karanović, Sandra, et al.
Publicado: (2021)

Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma
por: Boot, Arnoud, et al.
Publicado: (2020)

Ureteral Involvement and Diabetes Increase the Risk of Subsequent Bladder Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
por: Hu, Che-Yuan, et al.
Publicado: (2015)

Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway
por: Chen, I-Hsuan, et al.
Publicado: (2019)

Increased Risk of Urinary Tract Cancer in ESRD Patients Associated with Usage of Chinese Herbal Products Suspected of Containing Aristolochic Acid
por: Wang, Shuo-Meng, et al.
Publicado: (2014)

Robot-Assisted Laparoscopic Nephroureterectomy versus Hand-Assisted Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: A Matched Comparison Study
por: Hu, Che-Yuan, et al.
Publicado: (2015)

Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
por: Colin, Pierre, et al.
Publicado: (2016)

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience
por: Yang, Chen-Kuang, et al.
Publicado: (2014)

Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo
por: TAO, LE, et al.
Publicado: (2015)

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
por: Zhong, Wenlong, et al.
Publicado: (2017)

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2018)

Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy
por: Shan, Hongli, et al.
Publicado: (2020)

Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
por: Sheu, Zai-Lin, et al.
Publicado: (2022)

Laparoscopic nephroureterectomy for upper tract urothelial carcinoma – Update
por: Lin, Victor C., et al.
Publicado: (2016)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II
por: Yang, Tsung-Mu, et al.
Publicado: (2023)

Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma
por: Park, Bong Hee, et al.
Publicado: (2013)

Conservative Treatment for Upper Urinary Tract Urothelial Carcinoma
por: Traxer, Olivier, et al.
Publicado: (2021)

Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
por: He, Hong-Lin, et al.
Publicado: (2023)

Increased Upper and Lower Tract Urothelial Carcinoma in Patients with End-Stage Renal Disease: A Nationwide Cohort Study in Taiwan during 1997–2008
por: Wang, Shuo-Meng, et al.
Publicado: (2014)

Time to change the management of upper urinary tract urothelial carcinoma
por: Akand, Murat, et al.
Publicado: (2020)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
por: Grobet-Jeandin, Elisabeth, et al.
Publicado: (2021)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con
por: Seles, Maximilian, et al.
Publicado: (2021)

Hypercalcemia an exceptional complication in upper urinary tract urothelial carcinoma
por: Jandou, Issam, et al.
Publicado: (2021)

Therapeutic strategies for asymptomatic upper urinary tract urothelial carcinoma
por: Lin, Deng, et al.
Publicado: (2022)

Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group
por: Lin, Chung-Yu, et al.
Publicado: (2022)

Native Kidney Hydronephrosis Is Associated with Upper Urinary Tract Urothelial Carcinoma in Post-Kidney Transplantation Patients
por: Ho, Cheng-Ju, et al.
Publicado: (2021)

The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma
por: Zhang, Xiaodi, et al.
Publicado: (2021)

Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2019)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Nephroureterectomy increase 5 year survival in patients on dialysis with upper urinary tract urothelial carcinoma
por: Huang, Cih-En, et al.
Publicado: (2017)

Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area
por: Chang, Che-Wei, et al.
Publicado: (2021)

Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma
por: Kim, Gilhyang, et al.
Publicado: (2016)

Prognostic factors in laser treatment of upper urinary tract urothelial tumours
por: Niţă, Gh, et al.
Publicado: (2012)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
por: Smentkowski, Katherine E., et al.
Publicado: (2020)

Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs
por: Yang, Huang-Yu, et al.
Publicado: (2019)

DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer
por: Stiborová, Marie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qgn45qua82tuaifdp2botkr00l